Ono Pharmaceutical Co., Ltd.
OPHLY · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $746,857 | $1,185,927 | $4,042,676 | $4,514,730 |
| - Cash | $204,567 | $166,141 | $96,135 | $69,112 |
| + Debt | $146,678 | $8,862 | $9,168 | $8,802 |
| Enterprise Value | $688,968 | $1,028,648 | $3,955,709 | $4,454,420 |
| Revenue | $486,871 | $502,672 | $447,187 | $361,361 |
| % Growth | -3.1% | 12.4% | 23.8% | – |
| Gross Profit | $338,921 | $375,546 | $337,125 | $267,850 |
| % Margin | 69.6% | 74.7% | 75.4% | 74.1% |
| EBITDA | $91,540 | $178,435 | $161,896 | $123,620 |
| % Margin | 18.8% | 35.5% | 36.2% | 34.2% |
| Net Income | $50,047 | $127,977 | $112,723 | $80,519 |
| % Margin | 10.3% | 25.5% | 25.2% | 22.3% |
| EPS Diluted | 35.47 | 88.87 | 76.92 | 54.05 |
| % Growth | -60.1% | 15.5% | 42.3% | – |
| Operating Cash Flow | $82,459 | $110,660 | $159,610 | $61,829 |
| Capital Expenditures | -$7,990 | -$20,829 | -$14,497 | -$12,277 |
| Free Cash Flow | $74,469 | $89,831 | $145,113 | $49,552 |